Q-omics provides the consensus-scored RPL22P6 profile across patient tissues and cancer cell-line models. RPL22P6 expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in KIRP. Additionally, RPL22P6 RNA expression shows 3,239 significant gene co-expression associations, with the highest sampling consensus in UCEC. Together, these results highlight KIRP, and UCEC as cancer lineages where RPL22P6 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.